576 related articles for article (PubMed ID: 8880851)
1. Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists.
Hao JX; Xu XJ
Pain; 1996 Aug; 66(2-3):279-85. PubMed ID: 8880851
[TBL] [Abstract][Full Text] [Related]
2. Systemic excitatory amino acid receptor antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor and of the N-methyl-D-aspartate (NMDA) receptor relieve mechanical hypersensitivity after transient spinal cord ischemia in rats.
Xu XJ; Hao JX; Seiger A; Wiesenfeld-Hallin Z
J Pharmacol Exp Ther; 1993 Oct; 267(1):140-4. PubMed ID: 8229741
[TBL] [Abstract][Full Text] [Related]
3. Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia.
Nishiyama T
Can J Anaesth; 2000 Jul; 47(7):693-8. PubMed ID: 10930211
[TBL] [Abstract][Full Text] [Related]
4. NBQX, a competitive non-NMDA receptor antagonist, reduces degeneration due to focal spinal cord ischemia.
von Euler M; Seiger A; Holmberg L; Sundström E
Exp Neurol; 1994 Sep; 129(1):163-8. PubMed ID: 7925838
[TBL] [Abstract][Full Text] [Related]
5. Gabapentin and NMDA receptor antagonists interacts synergistically to alleviate allodynia in two rat models of neuropathic pain.
Shi T; Hao JX; Wiesenfeld-Hallin Z; Xu XJ
Scand J Pain; 2018 Oct; 18(4):687-693. PubMed ID: 29975670
[TBL] [Abstract][Full Text] [Related]
6. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy.
Qian J; Brown SD; Carlton SM
Brain Res; 1996 Apr; 715(1-2):51-62. PubMed ID: 8739622
[TBL] [Abstract][Full Text] [Related]
7. N-antipyrine-3, 4-dichloromaleimide, an effective cyclic imide for the treatment of chronic pain: the role of the glutamatergic system.
Quintão NL; da Silva GF; Antonialli CS; de Campos-Buzzi F; Corrêa R; Filho VC
Anesth Analg; 2010 Mar; 110(3):942-50. PubMed ID: 20185671
[TBL] [Abstract][Full Text] [Related]
8. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
[TBL] [Abstract][Full Text] [Related]
9. Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain.
Blackburn-Munro G; Bomholt SF; Erichsen HK
Neuropharmacology; 2004 Sep; 47(3):351-62. PubMed ID: 15275824
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors.
Wrathall JR; Teng YD; Choiniere D
Exp Neurol; 1996 Jan; 137(1):119-26. PubMed ID: 8566203
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat.
Chaplan SR; Malmberg AB; Yaksh TL
J Pharmacol Exp Ther; 1997 Feb; 280(2):829-38. PubMed ID: 9023297
[TBL] [Abstract][Full Text] [Related]
12. Characterization of audiogenic-like seizures in naive rats evoked by activation of AMPA and NMDA receptors in the inferior colliculus.
Yasuda S; Ishida N; Higashiyama A; Morinobu S; Kato N
Exp Neurol; 2000 Aug; 164(2):396-406. PubMed ID: 10915578
[TBL] [Abstract][Full Text] [Related]
13. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
[TBL] [Abstract][Full Text] [Related]
14. Effects of the competitive N-methyl-D-aspartate receptor antagonist, LY235959 [(-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid], on responding for cocaine under both fixed and progressive ratio schedules of reinforcement.
Allen RM; Carelli RM; Dykstra LA; Suchey TL; Everett CV
J Pharmacol Exp Ther; 2005 Oct; 315(1):449-57. PubMed ID: 16024734
[TBL] [Abstract][Full Text] [Related]
15. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
Wrathall JR; Teng YD; Marriott R
Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
[TBL] [Abstract][Full Text] [Related]
16. Dextromethorphan potentiates morphine antinociception at the spinal level in rats.
Chow LH; Huang EY; Ho ST; Lee TY; Tao PL
Can J Anaesth; 2004 Nov; 51(9):905-10. PubMed ID: 15525615
[TBL] [Abstract][Full Text] [Related]
17. Spinal AMPA receptor inhibition attenuates mechanical allodynia and neuronal hyperexcitability following spinal cord injury in rats.
Gwak YS; Kang J; Leem JW; Hulsebosch CE
J Neurosci Res; 2007 Aug; 85(11):2352-9. PubMed ID: 17549753
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury.
Bennett AD; Everhart AW; Hulsebosch CE
Brain Res; 2000 Mar; 859(1):72-82. PubMed ID: 10720616
[TBL] [Abstract][Full Text] [Related]
19. Lack of stereoselectivity for the antiallodynic effect of mexiletine in spinally injured rats.
Wu WP; Nordmark J; Wiesenfeld-Hallin Z; Xu XJ
Eur J Pain; 2000; 4(4):409-12. PubMed ID: 11124013
[TBL] [Abstract][Full Text] [Related]
20. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
